On August 16, 2022, President Biden signed the landmark Inflation Reduction Act of 2022– H.R.5376– into law, intending to lower costs on prescription drugs, health care, and energy. Here, we highlight the R&D opportunities associated…
On August 9th, 2022, President Biden signed H.R.4346 (also known as “CHIPS Plus” or “CHIPS and Science”) into law. An important distinction in the bill for research universities is the difference between appropriated funding and authorized funding
On June 30th, 2022, the House Appropriations Committee (HAC) approved the final two of 12 annual government funding bills for fiscal year 2023 (FY23). Six of those bills are expected to be considered in the House next week.
McAllister & Quinn’s Senior Vice President & General Counsel, Ed Williams and Vice President, Kellianne Lauer hosted a webinar to discuss our nation’s investments in critical research and development programs.
In the past month, the President signed into law the Fiscal Year (FY) 2022 Omnibus Bill that funds the Department of Health and Human Services (HHS) and released his budget request for FY23. FY22 funding levels for the HHS sub-agencies listed below represent some of the most significant funding increases in recent history.